Compare Inovio Pharmaceuticals Inc (INO) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Jones Lang LaSalle Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.91 (market cap $78.67M), while Jones Lang LaSalle Inc trades at $368.46 (market cap $16.69B). The key difference: Jones Lang LaSalle Inc is far larger — about 212.2× Inovio Pharmaceuticals Inc's market cap, and Jones Lang LaSalle Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | JLL | |
|---|---|---|
Market Cap | $78.67M | $16.69B |
Sector | Health | Real Estate |
52-Week High | $2.87 | $373.24 |
52-Week Low | $0.66 | $280.16 |
Enterprise Value | $50.00M | $19.45B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
